Paul Tudor Jones’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.44M Buy
18,700
+14,000
+298% +$2.91M 0.01% 1364
2026
Q1
$993K Sell
4,700
-27,300
-85% -$5.88M ﹤0.01% 2379
2025
Q4
$6.58M Sell
32,000
-13,500
-30% -$2.54M 0.01% 988
2025
Q3
$7.14M Sell
45,500
-8,700
-16% -$1.34M 0.01% 961
2025
Q2
$9.11M Buy
54,200
+52,600
+3,288% +$7.81M 0.02% 712
2025
Q1
$220K Sell
1,600
-10,300
-87% -$1.31M ﹤0.01% 2806
2024
Q4
$1.41M Buy
+11,900
New +$1.39M 0.01% 1485
2024
Q2
Sell
-3,200
Closed -$358K 2349
2024
Q1
$358K Buy
3,200
+200
+7% +$21.6K ﹤0.01% 1787
2023
Q4
$302K Buy
+3,000
New +$298K ﹤0.01% 2029
2023
Q1
Sell
-34,000
Closed -$2.62M 2440
2022
Q4
$2.62M Buy
34,000
+27,000
+386% +$2.05M 0.05% 484
2022
Q3
$467K Sell
7,000
-7,700
-52% -$488K 0.01% 1450
2022
Q2
$768K Buy
14,700
+8,200
+126% +$466K 0.02% 1035
2022
Q1
$367K Buy
6,500
+1,800
+38% +$96.4K 0.01% 1450
2021
Q4
$242K Buy
+4,700
New +$231K ﹤0.01% 2010

Other funds holding CAH

Paul Tudor Jones's CAH Position: Q3 2024 in Review

Paul Tudor Jones sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 304,010 shares — an estimated $29.9M sold.

Paul Tudor Jones first reported a position in CAH in Q2 2013 and held it in 33 quarters. The position peaked at $59.5M in Q1 2024. 1,016 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Paul Tudor Jones reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 304,010 Cardinal Health shares in Q3 2024, an estimated $29.9M.
  • Paul Tudor Jones first reported a position in Cardinal Health in Q2 2013 and held it in 33 quarters.
  • Paul Tudor Jones's Cardinal Health position peaked at $59.5M in Q1 2024.
  • 1,016 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.